Rodgers S - Search Results

1

Predictors of locoregional outcome in HER2-overexpressing breast cancer treated with neoadjuvant chemotherapy.

Arsenault D, Hurley J, Takita C, Reis IM, Zhao W, Rodgers S, Wright JL. Arsenault D, et al. Among authors: rodgers s. Am J Clin Oncol. 2015 Aug;38(4):348-52. doi: 10.1097/COC.0b013e31829d1eb8. Am J Clin Oncol. 2015. PMID: 23799288

2

Higher chest wall dose results in improved locoregional outcome in patients receiving postmastectomy radiation.

Panoff JE, Takita C, Hurley J, Reis IM, Zhao W, Rodgers SE, Gunaseelan V, Wright JL. Panoff JE, et al. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1192-9. doi: 10.1016/j.ijrobp.2011.02.045. Epub 2011 Apr 22. Int J Radiat Oncol Biol Phys. 2012. PMID: 21514739

3

The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients.

Hurley J, Reis IM, Rodgers SE, Gomez-Fernandez C, Wright J, Leone JP, Larrieu R, Pegram MD. Hurley J, et al. Breast Cancer Res Treat. 2013 Apr;138(3):783-94. doi: 10.1007/s10549-013-2497-y. Epub 2013 Mar 31. Breast Cancer Res Treat. 2013. PMID: 23542956 Clinical Trial.

4

Impact of surgery-radiation interval on locoregional outcome in patients receiving neo-adjuvant therapy and mastectomy.

Desai S, Hurley J, Takita C, Reis IM, Zhao W, Rodgers SE, Wright JL. Desai S, et al. Among authors: rodgers se. Breast J. 2013 Jul-Aug;19(4):427-30. doi: 10.1111/tbj.12140. Epub 2013 Jun 11. Breast J. 2013. PMID: 23750652

5

Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy.

Saigal K, Hurley J, Takita C, Reis IM, Zhao W, Rodgers SE, Wright JL. Saigal K, et al. Clin Breast Cancer. 2013 Oct;13(5):335-43. doi: 10.1016/j.clbc.2013.04.002. Epub 2013 Jul 10. Clin Breast Cancer. 2013. PMID: 23850216

6

Axillary response rates to neoadjuvant chemotherapy in breast cancer patients with advanced nodal disease.

Goel N, Yadegarynia S, Rodgers S, Kelly K, Collier A, Franceschi D, Moller M, Avisar E, Kesmodel SB. Goel N, et al. Among authors: rodgers s. J Surg Oncol. 2021 Jul;124(1):25-32. doi: 10.1002/jso.26480. Epub 2021 Apr 14. J Surg Oncol. 2021. PMID: 33852160

7

Parathyroid carcinoma.

Rodgers SE, Perrier ND. Rodgers SE, et al. Curr Opin Oncol. 2006 Jan;18(1):16-22. doi: 10.1097/01.cco.0000198019.53606.2b. Curr Opin Oncol. 2006. PMID: 16357559 Free article. Review.

8

Adjuvant therapy of gastrointestinal stromal tumors.

Koshenkov VP, Rodgers SE. Koshenkov VP, et al. Curr Opin Oncol. 2012 Jul;24(4):414-8. doi: 10.1097/CCO.0b013e328353d774. Curr Opin Oncol. 2012. PMID: 22572723 Review.

9

Predictors of incidental gallbladder cancer in patients undergoing cholecystectomy for benign gallbladder disease.

Koshenkov VP, Koru-Sengul T, Franceschi D, Dipasco PJ, Rodgers SE. Koshenkov VP, et al. J Surg Oncol. 2013 Feb;107(2):118-23. doi: 10.1002/jso.23239. Epub 2012 Aug 6. J Surg Oncol. 2013. PMID: 22886779

10

Number of lymph nodes removed during modified radical neck dissection for papillary thyroid cancer does not influence lateral neck recurrence.

Albuja-Cruz MB, Thorson CM, Allan BJ, Lew JI, Rodgers SE. Albuja-Cruz MB, et al. Surgery. 2012 Dec;152(6):1177-83. doi: 10.1016/j.surg.2012.08.025. Epub 2012 Oct 3. Surgery. 2012. PMID: 23040712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

651 results

Search Page

Filters